# Adalimumab

## Humira inj 40mg/0.4mL

| 藥物代碼           | IHUM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Monotherapy or in combination with methotrexate or other DMARDs for reducing of the signs & symptoms & to inhibit the progression of structural damage in adult patients with moderately to severely active RA. Monotherapy or in combination with other DMARDs for reducing the signs & symptoms of active arthritis in patients with psoriatic arthritis. Reduction of signs & symptoms in patients with active ankylosing spondylitis. Reduction of signs & symptoms & inducing & maintaining clinical remission in adult patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy or if they have also lost response to or are intolerant to infliximab. Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy & when other systemic therapies are medically less appropriate. Reduction of the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients 13-17 years. |
| 副作用             | Resp tract infections, leucopenia, anemia, increased lipids, headache, abdominal pain, nausea & vomiting, elevated liver enzymes, rash, musculoskeletal pain, inj site reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌               | Known hypersensitivity to adalimumab or any of the excipients of Humira.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 用法用量           | Adult RA, psoriatic arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis Single dose of 40 mg SC every other week. If not taking concomitantly with methotrexate, increasing the dosing frequency to 40 mg weekly may derive additional benefit. Crohn's disease 160 mg initially at day 1 (as four 40-mg inj in 1 day or as two 40-mg inj/day for 2 consecutive days), followed by 80 mg 2 weeks later (day 15). Another 2 weeks later (day 29) begin a maintenance dose of 40 mg every other week. Patients who experience decrease in their response may benefit from an increase in dose intensity to 40 mg every week. Plaque psoriasis Initially 80 mg, followed by 40 mg given every other week starting 1 week after the initial dose.                                                                                                                                                                                                                                                                                                         |
| 肝功能異常         | 無需調整劑量  There are no dosage adjustments provided in the manufacturer's labeling                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 孕期用藥建議       | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注射劑給藥建議途徑 | SC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

